Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey S. Farrow currently holds 43,316 shares of Global Blood Therapeutics, Inc. (GBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey S. Farrow has been a net seller of GBT stock. They have purchased $0 and sold $5.0M worth of shares.
Jeffrey S. Farrow's most recent insider trade was on Mar 19, 2026, when they sold 2,186 shares at $67.00 per share.
Jeffrey S. Farrow serves as Executive at Global Blood Therapeutics, Inc. (GBT). They have executed 71 insider transactions totaling $5.0M over their tenure at the company.
Jeffrey S. Farrow holds the position of Executive at Global Blood Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Jeffrey S. Farrow has shown a selling trading pattern, with $0 in total purchases and $5.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jeffrey S. Farrow was on Sep 1, 2022, when they sold $2.1M worth of GBT shares. This transaction involved 31,441 shares at $68.00 per share.
Jeffrey S. Farrow currently owns 43,316 shares of Global Blood Therapeutics, Inc. (GBT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey S. Farrow's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey S. Farrow has 71 Form 4 filings on record as an insider at Global Blood Therapeutics, Inc..
Set alerts for Jeffrey S. Farrow and 40,000+ other insiders.